en/health – 13. oldal

• What Today’s Weight-Loss Drug Headlines Really Mean for Patients—and for Our Culture
  2026-02-24

  Breakthrough obesity medications are reshaping treatment expectations, drug-company competition, and everyday conversations about bodies. Here’s what the latest headlines suggest—and how to interpret them with a health-first mindset.

• Weight‑Loss Drugs Are Everywhere—Here’s What to Know About Benefits, Policy Changes, and Scams
  2026-02-24

  Weight‑loss medications are reshaping healthcare and consumer behavior, but they also bring new safety risks and scam tactics. Here’s a practical guide to what’s changing, what to watch for, and how to protect yourself.

• AI Body Scans, Weight-Loss Drugs, and the New Wellness Marketplace: Benefits, Risks, and Red Flags
  2026-02-24

  AI body scans and prescription weight-loss medications are reshaping wellness—bringing new tools for tracking health, but also new privacy, safety, and scam risks. Here’s how to evaluate what’s helpful, what’s hype, and what to watch for.

• Weight Loss in 2026: What the Latest Headlines Mean for Your Health
  2026-02-24

  New reports highlight two big weight-loss trends: meal timing (bigger breakfasts, lighter dinners) and the rapid expansion of GLP-1 medications. Here’s what they mean in practical, health-first terms.

• Weight Loss in 2026: From Meal Timing to GLP-1 Drugs—and Why Stigma Still Hurts
  2026-02-24

  New headlines highlight a shifting weight-loss landscape: more attention to meal timing, rapid growth of GLP-1 medications, and an ongoing backlash against body shaming. Here’s what the science, policy, and culture debates mean for everyday health choices.

• Why Weight Loss Doesn’t Always Follow Hard Work: What to Check Before Changing Your Plan
  2026-02-23

  If you’re exercising consistently but gaining weight—or if fasting and medications aren’t delivering—there are practical, evidence-informed reasons. Here’s how to troubleshoot plateaus, choose the right tools, and know when to seek medical options.

• GLP-1 Weight-Loss Drugs: Real Risks, Fake Versions, and How to Protect Yourself
  2026-02-23

  As GLP-1 weight-loss medications surge in popularity, new concerns are emerging: unsafe prescribing, counterfeits, and legal battles over knockoffs. Here’s what to know to use these medicines more safely—and avoid scams.

• Weight-Loss Medications, Marathons, and Misinformation: What the Latest GLP-1 Headlines Mean for Your Health
  2026-02-23

  GLP-1 weight-loss drugs are reshaping how people lose weight—but safety concerns, counterfeit products, and the need for medical oversight are growing. Here’s what to know before starting (or buying) any weight-loss medication.

• Weight Loss in 2026: What New Evidence Says About Mounjaro, Intermittent Fasting and Strength Training
  2026-02-23

  Mounjaro (tirzepatide) is now approved for weight loss in some markets, but cost and access remain major barriers. Meanwhile, new reporting on research suggests intermittent fasting may not outperform simpler calorie-reduction approaches, reinforcing the value of sustainable habits and resistance tr

• Weight Loss in 2026: The “Ozempic Effect,” Mounjaro Access, and What Still Matters Most
  2026-02-23

  GLP-1 drugs are reshaping how people eat—and how restaurants serve—while high costs keep newer options like Mounjaro out of reach for many. Here’s what the latest headlines suggest, and what to focus on for sustainable results.